Mehta A, Pant A
J Med Case Rep. 2025; 19(1):93.
PMID: 40033413
PMC: 11877773.
DOI: 10.1186/s13256-025-05081-w.
Cifaldi C, Sgrulletti M, Cesare S, Rivalta B, Emanuele A, Colucci L
J Clin Med. 2025; 14(2.
PMID: 39860371
PMC: 11765721.
DOI: 10.3390/jcm14020363.
Husic A, Jaggi J, Muller B, Dashti D, Wirz S, Potlukova E
Eur J Case Rep Intern Med. 2024; 11(12):004822.
PMID: 39651377
PMC: 11623358.
DOI: 10.12890/2024_004822.
Gooding M, Hammoud D, Epling B, Rocco J, Laidlaw E, Kuriakose S
Front Immunol. 2024; 15:1441945.
PMID: 39559357
PMC: 11570994.
DOI: 10.3389/fimmu.2024.1441945.
Bes-Berlandier H, Garzaro M, Rouzaud C, Bodard S, Bille E, Ficheux M
Heliyon. 2024; 10(7):e29341.
PMID: 38623247
PMC: 11016716.
DOI: 10.1016/j.heliyon.2024.e29341.
The Neuro-Ophthalmology of Tuberculosis.
Shree R, Mahesh K, Takkar A, Modi M, Goyal M, Lal V
Neuroophthalmology. 2024; 48(2):73-92.
PMID: 38487360
PMC: 10936603.
DOI: 10.1080/01658107.2023.2281435.
A teenage girl with altered mental status and paraparesis.
Miyakawa R, Louie J, Keh C, Chen L, Javid B, Ernst J
J Clin Tuberc Other Mycobact Dis. 2024; 35:100425.
PMID: 38468819
PMC: 10926304.
DOI: 10.1016/j.jctube.2024.100425.
Infliximab for Intractable Paradoxical Reaction in Culture-Negative Tuberculosis Meningitis.
Kim D, Yoon T, Choi J, Lee S
J Clin Neurol. 2024; 20(2):226-228.
PMID: 38212666
PMC: 10921041.
DOI: 10.3988/jcn.2023.0290.
The use of TNF-α antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review.
Armange L, Lacroix A, Petitgas P, Arvieux C, Piau-Couapel C, Poubeau P
Eur J Clin Microbiol Infect Dis. 2023; 42(4):413-422.
PMID: 36795280
DOI: 10.1007/s10096-023-04564-2.
Impact and Tolerance of Immunosuppressive Treatments in Patients Living with HIV with Inflammatory or Autoimmune Diseases.
Guitton Z, Viget N, Surgers L, Cheret A, Fontier C, Deconinck L
Microorganisms. 2022; 10(10).
PMID: 36296168
PMC: 9610421.
DOI: 10.3390/microorganisms10101891.
CNS TB-IRIS Following Cessation of Adalimumab in an Adolescent With Crohn's Disease.
Christian E, Johnston A
Open Forum Infect Dis. 2022; 9(8):ofac367.
PMID: 35949406
PMC: 9356675.
DOI: 10.1093/ofid/ofac367.
Multiple Extrapulmonary Tuberculous Abscesses Developed Postpartum in a Non-HIV Patient Under Anti-tuberculosis Chemotherapy.
Papadopoulou E, Rampiadou C, Petsatodis E, Chloros D, Boutou A
Cureus. 2022; 14(1):e21395.
PMID: 35198302
PMC: 8855021.
DOI: 10.7759/cureus.21395.
Host Directed Therapies for Tuberculous Meningitis.
Davis A, Donovan J, Bremer M, van Toorn R, Schoeman J, Dadabhoy A
Wellcome Open Res. 2022; 5():292.
PMID: 35118196
PMC: 8792876.
DOI: 10.12688/wellcomeopenres.16474.2.
Intractable Tuberculous Meningitis With Paradoxical Reactions Treated by Anti-Tissue Necrosis Factor-α Therapy.
Kim K, Kim H, Kim H, Kim S, Lee S, Koo Y
Neurol Clin Pract. 2021; 11(4):e555-e557.
PMID: 34484957
PMC: 8382441.
DOI: 10.1212/CPJ.0000000000000946.
Potential disease trigger as a therapeutic option: infliximab for paradoxical reaction in tuberculosis of the central nervous system.
Briner M, Oberholzer M, Wagner F, Chan A
BMJ Case Rep. 2021; 14(8).
PMID: 34340991
PMC: 8330559.
DOI: 10.1136/bcr-2020-235511.
Neuro-ophthalmic manifestations of tuberculosis.
Dhiman R, Lakra S, Panda P, Hemachandran N, Sharma S, Saxena R
Eye (Lond). 2021; 36(1):15-28.
PMID: 34127839
PMC: 8727585.
DOI: 10.1038/s41433-021-01619-6.
Use of Infliximab to Treat Paradoxical Tuberculous Meningitis Reactions.
Marais B, Cheong E, Fernando S, Daniel S, Watts M, Berglund L
Open Forum Infect Dis. 2021; 8(1):ofaa604.
PMID: 33542942
PMC: 7846119.
DOI: 10.1093/ofid/ofaa604.
Tuberculosis IRIS: Pathogenesis, Presentation, and Management across the Spectrum of Disease.
Quinn C, Poplin V, Kasibante J, Yuquimpo K, Gakuru J, Cresswell F
Life (Basel). 2020; 10(11).
PMID: 33138069
PMC: 7693460.
DOI: 10.3390/life10110262.
Tumor necrosis factor antagonists for paradoxical inflammatory reactions in the central nervous system tuberculosis: Case report and review.
Santin M, Escrich C, Majos C, Llaberia M, Grijota M, Grau I
Medicine (Baltimore). 2020; 99(43):e22626.
PMID: 33120751
PMC: 7581161.
DOI: 10.1097/MD.0000000000022626.
Use of steroids to treat anti-tumor necrosis factor α induced tuberculosis-associated immune reconstitution inflammatory syndrome: Case report and literature review.
Nabeya D, Kinjo T, Yamaniha K, Yamazato S, Tome R, Miyagi K
Medicine (Baltimore). 2020; 99(43):e22076.
PMID: 33120729
PMC: 7581145.
DOI: 10.1097/MD.0000000000022076.
